AYLA logo

Ayala Pharmaceuticals (AYLA) CAPEX

Annual CAPEX

$5000.00
-$40.00 K-88.89%

December 31, 2021

Summary

Performance

1-Year Change

-88.89%

3-Year Change

-

5-Year Change

-

15-Year Change

-

AYLA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.33 M
AYLA annual capital expenditures is currently -99.62% below its historical high of $1.33 million

3-Year Low

$5000.00
AYLA annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
AYLA previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
AYLA next annual earnings announcement has not yet been scheduled

OtherAYLAcash flowmetrics:

Annual FCF

-$38.36 M
AYLA annual free cash flow is -$38.36 million

Annual CFO

-$38.36 M
AYLA annual cash flow from operations is -$38.36 million

Annual CFI

-$5000.00
AYLA annual cash flow from investing activities is -$5000.00

Annual CFF

$33.33 M
AYLA annual cash flow from financing activities is $33.33 million

Quarterly CAPEX

N/A

September 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

AYLA Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$593.00 K
AYLA quarterly capital expenditures is currently at an all-time high

3-Year Low

$0.00
AYLA quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AYLA previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AYLA next earnings announcement has not yet been scheduled

OtherAYLAcash flowmetrics:

Quarterly FCF

-$9.34 M
AYLA quarterly free cash flow is -$9.34 million

Quarterly CFO

-$9.34 M
AYLA quarterly cash flow from operations is -$9.34 million

Quarterly CFI

$0.00
AYLA quarterly cash flow from investing activities is $0.00

Quarterly CFF

$468.00 K
AYLA quarterly cash flow from financing activities is $468.00 thousand

TTM CAPEX

N/A

September 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

AYLA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.33 M
AYLA TTM capital expenditures is currently at an all-time high

3-Year Low

$5000.00
AYLA TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AYLA previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AYLA next earnings announcement has not yet been scheduled

OtherAYLAcash flowmetrics:

TTM FCF

-$34.13 M
AYLA TTM free cash flow is -$34.13 million

TTM CFO

-$34.13 M
AYLA TTM cash flow from operations is -$34.13 million

TTM CFI

$0.00
AYLA TTM cash flow from investing activities is $0.00

TTM CFF

$4.46 M
AYLA TTM cash flow from financing activities is $4.46 million

AYLA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-88.9%--
3 y3 years---
5 y5 years---

AYLA CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-year-99.6%at low
alltimeall time-99.6%at low

Ayala Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2021
$5000.00(-88.9%)
$0.00(-100.0%)
$5000.00(-120.8%)
Sep 2021
-
$2000.00(-33.3%)
-$24.00 K(-260.0%)
Jun 2021
-
$3000.00(-110.3%)
$15.00 K(-66.7%)
Dec 2020
$45.00 K
-$29.00 K(-170.7%)
$45.00 K(-92.6%)
Sep 2020
-
$41.00 K(+215.4%)
$605.00 K(+7.3%)
DateAnnualQuarterlyTTM
Jun 2020
-
$13.00 K(-35.0%)
$564.00 K(-50.7%)
Mar 2020
-
$20.00 K(-96.2%)
$1.14 M(-14.0%)
Dec 2019
$1.33 M
$531.00 K(>+9900.0%)
$1.33 M(+66.5%)
Sep 2019
-
$0.00(-100.0%)
$799.00 K(0.0%)
Jun 2019
-
$593.00 K(+187.9%)
$799.00 K(+287.9%)
Mar 2019
-
$206.00 K
$206.00 K

FAQ

  • What is Ayala Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Ayala Pharmaceuticals?
  • What is the all time high TTM CAPEX for Ayala Pharmaceuticals?

What is Ayala Pharmaceuticals annual capital expenditures?

The current annual CAPEX of AYLA is $5000.00

What is the all time high annual CAPEX for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high annual capital expenditures is $1.33 M

What is Ayala Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, AYLA annual capital expenditures has changed by -$40.00 K (-88.89%)

What is the all time high quarterly CAPEX for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high quarterly capital expenditures is $593.00 K

What is the all time high TTM CAPEX for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high TTM capital expenditures is $1.33 M